Patent directory · USPTO A61K / A61P
Patents matching “Amazentis SA”
34 pharma patents match "Amazentis SA" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 34 pharmaceutical patents matching "Amazentis SA" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12310943
Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders
granted -
US 12297182
Compositions comprising an urolithin compound
granted -
US 12220424
Compositions comprising nicotinamide riboside and a urolithin
granted -
US 12109190
Urolithins as immune response enhancers
granted -
US 12036205
Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders
granted -
US 12030863
Prodrugs of urolithins and uses thereof
granted -
US 11969408
Method for improving mitophagy in subjects
granted -
US 11931336
Enhancing autophagy or increasing longevity by administration of urolithins
granted -
US 11931335
Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof
granted -
US 11925616
Compositions comprising urolithin compounds
granted -
US 11903922
Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders
granted -
US 11878964
Compositions comprising an urolithin compound
granted -
US 11426380
Urolithins as immune response enhancers
granted -
US 11337957
Compositions comprising urolithin compounds
granted -
US 11234960
Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders
granted -
US 11180468
Prodrugs of urolithins and uses thereof
granted -
US 11166937
Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders
granted -
US 11166972
Compositions comprising nicotinamide riboside and a urolithin
granted -
US 11020373
Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof
granted -
US 10988453
Compositions comprising an urolithin compound
granted -
US 10857126
Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders
granted -
US 10792276
Urolithins as immune response enhancers
granted -
US 10695320
Compositions comprising urolithin compounds
granted -
US 10532992
Prodrugs of urolithins and uses thereof
granted